Search research articles
Contact Us
Filters
Showing results (131-140 of 155) with videos related to
Page
of 16
Sort By:
Diabetologia
|
May 1, 1993
A mutation (Trp1193-->Leu1193) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance
M Iwanishi, T Haruta, Y Takata, et al.
Acta Paediatrica Japonica : Overseas Edition
|
December 1, 1995
Effects of the recent great Hanshin-Awaji earthquake on emergency pediatric care
K Okura, K Kamimura, K Hamahata, et al.
The Japanese Journal of Antibiotics
|
April 1, 1988
[Clinical evaluation of aztreonam against pediatric purulent meningitis]
R Fujii, H Meguro, T Nishimura, et al.
Metabolism: Clinical and Experimental
|
December 1, 1996
The dominant negative effect of a kinase-defective insulin receptor on insulin-like growth factor-I-stimulated signaling in Rat-1 fibroblasts
Y Takata, T Imamura, T Haruta, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
August 17, 2001
Potential role of Gab1 and phospholipase C-gamma in osmotic shock-induced glucose uptake in 3T3-L1 adipocytes
E Ueno, T Haruta, T Uno, et al.
The Japanese Journal of Antibiotics
|
March 1, 1981
[Fundamental and clinica evaluation of cefoxitin in children (author's transl)]
Y Kobayashi, Y Morikawa, T Haruta, et al.
The Journal of Biological Chemistry
|
January 23, 1999
The functional role of CrkII in actin cytoskeleton organization and mitogenesis
N Nakashima, D W Rose, S Xiao, et al.
The Journal of Biological Chemistry
|
June 5, 1998
Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin
A G Kayali, J Eichhorn, T Haruta, et al.
The Journal of Biological Chemistry
|
December 9, 1994
Two naturally occurring mutations in the kinase domain of insulin receptor accelerate degradation of the insulin receptor and impair the kinase activity
T Imamura, Y Takata, T Sasaoka, et al.
Diabetes
|
May 4, 2001
Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma
M Iwata, T Haruta, I Usui, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 155) with videos related to
Sort By:
Page
of 16
Diabetologia
|
May 1, 1993
A mutation (Trp1193-->Leu1193) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance
M Iwanishi, T Haruta, Y Takata, et al.
Acta Paediatrica Japonica : Overseas Edition
|
December 1, 1995
Effects of the recent great Hanshin-Awaji earthquake on emergency pediatric care
K Okura, K Kamimura, K Hamahata, et al.
The Japanese Journal of Antibiotics
|
April 1, 1988
[Clinical evaluation of aztreonam against pediatric purulent meningitis]
R Fujii, H Meguro, T Nishimura, et al.
Metabolism: Clinical and Experimental
|
December 1, 1996
The dominant negative effect of a kinase-defective insulin receptor on insulin-like growth factor-I-stimulated signaling in Rat-1 fibroblasts
Y Takata, T Imamura, T Haruta, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
August 17, 2001
Potential role of Gab1 and phospholipase C-gamma in osmotic shock-induced glucose uptake in 3T3-L1 adipocytes
E Ueno, T Haruta, T Uno, et al.
The Japanese Journal of Antibiotics
|
March 1, 1981
[Fundamental and clinica evaluation of cefoxitin in children (author's transl)]
Y Kobayashi, Y Morikawa, T Haruta, et al.
The Journal of Biological Chemistry
|
January 23, 1999
The functional role of CrkII in actin cytoskeleton organization and mitogenesis
N Nakashima, D W Rose, S Xiao, et al.
The Journal of Biological Chemistry
|
June 5, 1998
Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin
A G Kayali, J Eichhorn, T Haruta, et al.
The Journal of Biological Chemistry
|
December 9, 1994
Two naturally occurring mutations in the kinase domain of insulin receptor accelerate degradation of the insulin receptor and impair the kinase activity
T Imamura, Y Takata, T Sasaoka, et al.
Diabetes
|
May 4, 2001
Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma
M Iwata, T Haruta, I Usui, et al.
Page
of 16